1. Home
  2. SRI vs MCRB Comparison

SRI vs MCRB Comparison

Compare SRI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.81

Market Cap

172.9M

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$17.19

Market Cap

162.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
MCRB
Founded
1965
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
162.7M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
SRI
MCRB
Price
$5.81
$17.19
Analyst Decision
Buy
Hold
Analyst Count
1
3
Target Price
$16.00
$14.33
AVG Volume (30 Days)
167.1K
323.3K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$874,357,000.00
$351,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.68
N/A
P/E Ratio
N/A
$28.23
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$6.53
52 Week High
$9.10
$29.98

Technical Indicators

Market Signals
Indicator
SRI
MCRB
Relative Strength Index (RSI) 43.07 49.93
Support Level $5.54 $16.61
Resistance Level $5.85 $18.86
Average True Range (ATR) 0.21 3.42
MACD 0.07 -0.19
Stochastic Oscillator 84.31 11.70

Price Performance

Historical Comparison
SRI
MCRB

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: